Btk inhibitors in atherosclerosis

    Research output: Contribution to journalReview articlepeer-review


    In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.

    Original languageEnglish (US)
    Pages (from-to)2601-2602
    Number of pages2
    Issue number24
    StatePublished - Jun 14 2018

    ASJC Scopus subject areas

    • Biochemistry
    • Immunology
    • Hematology
    • Cell Biology

    Fingerprint Dive into the research topics of 'Btk inhibitors in atherosclerosis'. Together they form a unique fingerprint.

    Cite this